감마 나이프 시장 : 적응증별, 해부학적 구조별, 용도별 - 세계 예측(2025-2030년)

The Gamma Knife Market was valued at USD 352.56 million in 2023, expected to reach USD 374.91 million in 2024, and is projected to grow at a CAGR of 6.82%, to USD 559.63 million by 2030.

Gamma Knife is a specialized tool used in radiosurgery to treat brain disorders, focusing on delivering precise radiation therapy to target areas with minimal damage to surrounding tissue. The necessity of Gamma Knife stems from its non-invasive approach, providing essential treatment for patients with brain tumors, arteriovenous malformations, and certain neurological conditions that are inoperable using traditional surgery. Its application spans neurosurgery and oncology, employed by hospitals and specialty clinics prioritizing high precision and reduced recovery times, which enhances patient outcomes and operational efficiency.

The market for Gamma Knife technology is significantly shaped by factors such as the rising prevalence of neurological disorders, advancements in medical technologies, and the increasing demand for minimally invasive procedures. The aging population and enhanced healthcare infrastructure in emerging economies present substantial opportunities for market expansion. Key market growth opportunities include expanding applications in functional neurosurgery and the integration of AI for improved treatment planning. Companies can capitalize on these opportunities by investing in research and collaborating with technological innovators to refine imaging and precision.

However, limitations such as high initial investment costs, the need for skilled professionals, and regulatory challenges can impede market growth. Competition from alternative non-invasive technologies like CyberKnife and linear accelerators also presents challenges that companies need to strategically navigate. Effective strategies to overcome these include focusing on cost reduction through technological advancements and partnerships to enhance treatment accessibility and affordability.

The best potential areas for innovation and research include developing enhanced imaging techniques and exploring new therapeutic areas for radiosurgery. Insight into the competitive landscape reveals a consolidated market with major players focusing on differentiated technology features and strategic partnerships to strengthen their positions. Continued market growth will likely rely on sustained innovation and investment in overcoming operational barriers, ensuring that Gamma Knife radiotherapy remains at the forefront of treatment options for brain-related health conditions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gamma Knife Market

The Gamma Knife Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing risk of neurological disorders among the population
  • Expanding availability of healthcare services due to government policies
  • Availability of reimbursement policies and insurance
• Market Restraints
  • High cost of procedures and equipment
• Market Opportunities
  • Advancements in gamma knife technologies
  • Popularity of minimally invasive surgeries in economies
• Market Challenges
  • Stringent regulations governing gamma knife

Porter's Five Forces: A Strategic Tool for Navigating the Gamma Knife Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gamma Knife Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gamma Knife Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gamma Knife Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gamma Knife Market

A detailed market share analysis in the Gamma Knife Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gamma Knife Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gamma Knife Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gamma Knife Market

A strategic analysis of the Gamma Knife Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gamma Knife Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Akesis, Inc., American Shared Hospital Services, Blount Memorial Hospital, Brainlab AG, Brainlab AG by Smith & Nephew PLC, Elekta AB, General Electric Company, Hitachi, Ltd., ISOTREND Spol. S r.o., Koninklijke Philips N.V., MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., Nordion (Canada) Inc. by Sterigenics U.S., LLC, Panacea Medical Technologies Pvt. Ltd., and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Gamma Knife Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Indication, market is studied across Benign Tumors, Functional Disorders, Malignant Tumors, and Vascular Disorders.
• Based on Anatomy, market is studied across Head and Neck.
• Based on Application, market is studied across Arteriovenous Malformations, Brain Metastases, Brain Tumors, and Trigeminal Neuralgia.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing risk of neurological disorders among the population
    • 5.1.1.2. Expanding availability of healthcare services due to government policies
    • 5.1.1.3. Availability of reimbursement policies and insurance
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of procedures and equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in gamma knife technologies
    • 5.1.3.2. Popularity of minimally invasive surgeries in economies
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations governing gamma knife
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gamma Knife Market, by Indication

• 6.1. Introduction
• 6.2. Benign Tumors
• 6.3. Functional Disorders
• 6.4. Malignant Tumors
• 6.5. Vascular Disorders

7. Gamma Knife Market, by Anatomy

• 7.1. Introduction
• 7.2. Head
• 7.3. Neck

8. Gamma Knife Market, by Application

• 8.1. Introduction
• 8.2. Arteriovenous Malformations
• 8.3. Brain Metastases
• 8.4. Brain Tumors
• 8.5. Trigeminal Neuralgia

9. Americas Gamma Knife Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Gamma Knife Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Gamma Knife Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Accuray Incorporated
• 2. Akesis, Inc.
• 3. American Shared Hospital Services
• 4. Blount Memorial Hospital
• 5. Brainlab AG
• 6. Brainlab AG by Smith & Nephew PLC
• 7. Elekta AB
• 8. General Electric Company
• 9. Hitachi, Ltd.
• 10. ISOTREND Spol. S r.o.
• 11. Koninklijke Philips N.V.
• 12. MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.
• 13. Nordion (Canada) Inc. by Sterigenics U.S., LLC
• 14. Panacea Medical Technologies Pvt. Ltd.
• 15. Varian Medical Systems, Inc.